CTSH Gene
Overview
flowchart TD
CTSH["CTSH"] -->|"risk factor for"| Alzheimer_s_disease["Alzheimer's disease"]
CTSH["CTSH"] -->|"involved in"| Amyloid_beta_protein_precursor["Amyloid-beta protein precursor processing"]
CTSH["CTSH"] -->|"activates"| Als["Als"]
CTSH["CTSH"] -->|"activates"| Ms["Ms"]
CTSH["CTSH"] -->|"activates"| Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"]
CTSH["CTSH"] -->|"associated with"| Alzheimer["Alzheimer"]
CTSH["CTSH"] -->|"associated with"| Dementia["Dementia"]
CTSH["CTSH"] -->|"associated with"| Ms["Ms"]
CTSH["CTSH"] -->|"therapeutic target"| Alzheimer["Alzheimer"]
CTSH["CTSH"] -->|"therapeutic target"| Ms["Ms"]
CTSH["CTSH"] -->|"therapeutic target"| Dementia["Dementia"]
CTSH["CTSH"] -->|"therapeutic target"| Als["Als"]
CTSH["CTSH"] -->|"activates"| Alzheimer["Alzheimer"]
CTSH["CTSH"] -->|"interacts with"| C1QB["C1QB"]
style CTSH fill:#4fc3f7,stroke:#333,color:#000
...
CTSH Gene
Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-gene">
CTSH is a gene involved in cellular processes relevant to neurodegeneration.
CTSH Gene Full Name: Cathepsin H [@jansen2019]
Chromosome: 15q25.1 [@hook2018]
NCBI Gene ID: 1515 [@muellersteiner2006]
OMIM ID: 601009 [@bednarski1997]
Ensembl ID: ENSG00000103852 [@cataldo2000]
UniProt ID: P09668 [@nakanishi2003]
Summary CTSH encodes cathepsin H, a lysosomal cysteine protease belonging to the papain family. This enzyme has been implicated in [Alzheimer disease](/diseases/alzheimers-disease) (AD) through genome-wide association studies (GWAS), with elevated expression observed in AD brains [1][2]. CTSH plays important roles in protein degradation, antigen processing, and APP metabolism, making it a gene of interest in neurodegenerative disease research. [@tolppanen2013]
Function
Enzymatic Properties Cathepsin H is a cysteine protease with unique characteristics among lysosomal cathepsins:
Endopeptidase activity: Cleaves peptide bonds within protein substratesExopeptidase activity: Possesses aminopeptidase activity (monopeptidyl dipeptidase)Optimal pH: 5.5-6.5 in lysosomesStructure: Single-chain glycoprotein (~253 amino acids)Activation: Processed from pro-cathepsin H (37 kDa) to mature form (27 kDa)Substrate Specificity Cathepsin H degrades various substrates including:
Cytoskeletal proteins: Tubulin, actinExtracellular matrix: Fibronectin, lamininAPP and derivatives: May process [amyloid precursor protein](/entities/app-protein)[Tau protein](/proteins/tau): Potential to cleave tau[Alpha-synuclein](/proteins/alpha-synuclein): May degrade Lewy body componentsCellular Functions
Protein degradation: Lysosomal protein turnoverAntigen processing: MHC class II antigen presentationHormone processing: Activation of peptide hormonesWound healing: Extracellular matrix remodelingCell signaling: Regulation of growth factors
Disease Associations
Alzheimer Disease CTSH has been identified as an AD risk gene through GWAS [1][2]. Key associations include:
Genetic association: Common variants in CTSH locus associated with increased AD riskGene expression: Elevated CTSH expression in AD brain, particularly in [microglia](/cell-types/microglia-neuroinflammation)Amyloid metabolism: May influence APP processing and [Aβ](/proteins/amyloid-beta) generationNeuroinflammation: Upregulated in response to amyloid depositionParkinson Disease
Elevated CTSH in substantia nigra of PD patients
May contribute to alpha-synuclein degradation
Potential role in Lewy body formation
Other Neurodegenerative Conditions
Lewy Body Dementia: Increased cathepsin H in affected brain regionsFrontotemporal Dementia: Altered lysosomal protease expressionAmyotrophic Lateral Sclerosis: Dysregulated in motor [neurons](/entities/neurons)Expression Pattern CTSH is expressed in various tissues:
Brain: Neurons, microglia, [astrocytes](/entities/astrocytes)Immune system: Macrophages, dendritic cellsLiver: HepatocytesKidney: Tubular cellsLung: Alveolar macrophagesIn the brain, CTSH is particularly expressed in:
Microglial cells (brain macrophages)
Certain neuronal populations
Vascular endothelial cells
Therapeutic Implications
Drug Development CTSH represents a potential therapeutic target:
Inhibitor development: Selective CTSH inhibitors could modulate amyloid metabolismActivity modulators: Compounds enhancing CTSH activity may improve protein clearance[Blood-brain barrier](/entities/blood-brain-barrier) considerations: CNS-penetrant compounds neededBiomarker Potential
CTSH levels in cerebrospinal fluid (CSF) may serve as a biomarker
Microglial activation marker
Potential for disease progression tracking
Interactions and Pathway Context
Animal Models
Knockout Studies Ctsh-deficient mice show:
Accumulation of lysosomal storage material
Altered immune function
Deficits in antigen processing
No severe neurodegeneration under normal conditions
Transgenic Models
CTSH overexpression in mouse brain leads to altered amyloid metabolism
Modulates Aβ plaque formation in APP transgenic mice
Clinical Significance
Genetic Testing
CTSH variants are not routinely tested clinically
Associated risk variants are common in population
Research use for understanding disease mechanisms
Biomarkers
CSF cathepsin H levels under investigation
Potential marker for microglial activation
Comparative Biology Cathepsin H is conserved across species:
Humans: CTSH geneMice: Ctsh geneZebrafish: ctsh genesDrosophila: Cathepsin L-like proteasesSee Also
[Cathepsin Family](/genes/cat)](/genes)
[Alzheimer Disease](/diseases/alzheimers-disease)
[Lysosomal Proteases in Neurodegeneration](/diseases/neurodegeneration)](/diseases/neurodegeneration)
[APP Processing Pathways](/genes/th)](/genes)
[Microglia in Neurodegeneration](/cell-types/microglia)](/entities/microglia)
[Parkinson Disease](/diseases/parkinsons-disease)
Pathway Diagram The following diagram shows the key molecular relationships involving CTSH Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description